The NTIS website and supporting ordering systems are undergoing a major upgrade from 8PM on September 25th through approximately October 6. During that time, much of the functionality, including subscription and product ordering, shipping, etc., will not be available. You may call NTIS at 1-800-553-6847 or (703) 605-6000 to place an order but you should expect delayed shipment. Please do NOT include credit card numbers in any email you might send NTIS.
Documents in the NTIS Technical Reports collection are the results of federally funded research. They are directly submitted to or collected by NTIS from Federal agencies for permanent accessibility to industry, academia and the public.  Before purchasing from NTIS, you may want to check for free access from (1) the issuing organization's website; (2) the U.S. Government Printing Office's Federal Digital System website http://www.gpo.gov/fdsys; (3) the federal government Internet portal USA.gov; or (4) a web search conducted using a commercial search engine such as http://www.google.com.
Accession Number ADA570898
Title New Approach to Identify Novel Regulators of Myc Oncoprotein Stability.
Publication Date Sep 2012
Media Count 16p
Personal Author L. Z. Penn
Abstract The Myc oncoprotein is deregulated in the majority of breast cancers yet it has not been possible to develop a therapeutic to target Myc using traditional approaches. It has recently been shown that targeting Myc for degradation may offer a new therapeutic strategy to decrease Myc levels and kill tumor cells that are addicted to this potent oncogene. Identifying Myc protein regulatory mechanisms has been a time and labor-intensive process using classical methods to measure endogenous Myc half-life. Indeed, only one pathway has been identified to date. To facilitate this research our concept was that we could build a Myc stability probe by generating an in-frame fusion protein of Myc with a fluorescent protein (Myc-FP). After de novo synthesis, some FPs require hours to fold properly before they will exhibit fluorescence. Our concept was that if Myc-FP was turned over every 30 min, like Myc, then the short half-life Myc-FP would not demonstrate fluorescence, but if Myc was deregulated at the level of protein turnover, then Myc-FP would exhibit fluorescence. This switchable Myc stability probe could then be used to rapidly screen for regulators of Myc turnover. This concept has been validated and this new research tool developed, as proposed.
Keywords Anti-breast cancer therapeutics
Breast cancer
Canada
Cells(Biology)
Degradation
Fluorescence
Fluorescent protein
Foreign reports
High content screening
Kill probabilities
Measurement
Myc oncogene
Neoplasms
Oncogenesis
Potency
Protein turnover
Proteins
Stability
Stability probe
Therapy


 
Source Agency Non Paid ADAS
NTIS Subject Category 57E - Clinical Medicine
Corporate Author Army Medical Research and Materiel Command (Provisional), Fort Detrick, MD.
Document Type Technical report
Title Note Final rept. 1 Sep 2011-31 Aug 2012.
NTIS Issue Number 1315
Contract Number W81XWH-11-1-0120

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader